Cargando…

Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas

BACKGROUND: Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied. OBJECTIVES: To characterize cut...

Descripción completa

Detalles Bibliográficos
Autores principales: Plana‐Pla, A., García, B., Munera‐Campos, M., Catasus, N., Serra Arenas, E., Blanco, I., Castellanos Perez, E., Bielsa, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543204/
https://www.ncbi.nlm.nih.gov/pubmed/35490384
http://dx.doi.org/10.1111/jdv.18190
_version_ 1784804320571555840
author Plana‐Pla, A.
García, B.
Munera‐Campos, M.
Catasus, N.
Serra Arenas, E.
Blanco, I.
Castellanos Perez, E.
Bielsa, I.
author_facet Plana‐Pla, A.
García, B.
Munera‐Campos, M.
Catasus, N.
Serra Arenas, E.
Blanco, I.
Castellanos Perez, E.
Bielsa, I.
author_sort Plana‐Pla, A.
collection PubMed
description BACKGROUND: Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied. OBJECTIVES: To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity. METHODS: We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype‐ and genotype‐based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved. RESULTS: Forty‐nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque‐like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma‐neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque‐like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque‐like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype‐based classes. CONCLUSIONS AND RELEVANCE: Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis.
format Online
Article
Text
id pubmed-9543204
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95432042022-10-14 Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas Plana‐Pla, A. García, B. Munera‐Campos, M. Catasus, N. Serra Arenas, E. Blanco, I. Castellanos Perez, E. Bielsa, I. J Eur Acad Dermatol Venereol Jeadv September Issue BACKGROUND: Neurofibromatosis type 2 (NF2) is a genetic disease characterized by the appearance of multiple tumours in the nervous system. Cutaneous lesions are common and may provide useful diagnostic and prognostic information, but they have not been widely studied. OBJECTIVES: To characterize cutaneous lesions in a Spanish cohort of patients with NF2 and investigate associations with clinical and genetic severity. METHODS: We studied the clinical and histologic characteristics of cutaneous lesions in 49 patients with NF2 and analysed correlations with phenotype‐ and genotype‐based severity scores. We collected information on the presence/absence of cutaneous lesions, location, age at onset, type of lesion, and histologic features. We also studied level of systemic involvement and genetic mutations involved. RESULTS: Forty‐nine patients (31 women [63.3%] and 18 men [36.7%]) were analysed, and 33 (67.3%) had cutaneous lesions presumed to be schwannomas. According to their clinical form, they were distributed as follows: 24 patients (48%) had deep tumours, 21 (42%) had plaque‐like lesions, and 3 (6%) had superficial tumours. Histologic examination from 27 lesions analysed out 23 patients showed classic schwannoma or hybrid schwannoma‐neurofibroma features in the 8 deep tumours biopsied and plexiform schwannoma features in the 17 plaque‐like lesions and the 2 superficial tumours analysed. Early onset (first 2 decades of life) was reported by all patients with plaques and superficial tumours. In our cohort, 100% of the patients with plaque‐like lesions and superficial tumours with microscopic features of plexiform schwannoma were in the 2 groups with the most severe clinical phenotypes, and 82.6% of them were in the 3 most severe genotype‐based classes. CONCLUSIONS AND RELEVANCE: Cutaneous lesions, specially plexiform schwannomas, are common in NF2, and they usually appear at an early age providing useful diagnostic and prognostic information. These tumours are part of the spectrum of cutaneous manifestations in this disease. Although its diagnostic and prognostic value has been pointed out, there are few studies focussed on their analysis. John Wiley and Sons Inc. 2022-05-21 2022-09 /pmc/articles/PMC9543204/ /pubmed/35490384 http://dx.doi.org/10.1111/jdv.18190 Text en © 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Jeadv September Issue
Plana‐Pla, A.
García, B.
Munera‐Campos, M.
Catasus, N.
Serra Arenas, E.
Blanco, I.
Castellanos Perez, E.
Bielsa, I.
Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title_full Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title_fullStr Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title_full_unstemmed Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title_short Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
title_sort skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
topic Jeadv September Issue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543204/
https://www.ncbi.nlm.nih.gov/pubmed/35490384
http://dx.doi.org/10.1111/jdv.18190
work_keys_str_mv AT planaplaa skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT garciab skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT muneracamposm skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT catasusn skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT serraarenase skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT blancoi skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT castellanospereze skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT bielsai skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas
AT skinlesionsinneurofibromatosistype2diagnosticandprognosticsignificanceofcutaneousplexiformschwannomas